IR-Med Inc. announced that final data from a study conducted at two medical centers, Beit Rivka Hospital, and Rabin Medical Center, both in Petah Tikva and owned by Clalit, the world?s second health maintenance organization (HMO) and the in Israel, will be presented at the National Pressure Injury Advisory Panel(NPIAP) 2024 Annual Conference which will take place in San Antonio, Texas on February 16-17, 2024. The single arm, bi-center, open label, safety and efficacy study evaluated PressureSafe?, IR-MED?s decision support device, which uses infra-red spectroscopy combined with an AI-based algorithm to diagnose Stage 1 pressure injuries, compared to standard of care visual and tactile inspection. IR-MED?s clinical and execute team will demonstrate PressureSafe at booth #102 at NPIAP 2024, which is attended by the world?s top thought leaders and practitioners in the prevention and treatment of pressure injuries.